The key considerations include: The stage and severity of liver disease simple steatosis versus NASH, fibrosis, or cirrhosis Overall liver function as assessed through blood tests and clinical evaluation Concurrent chronic alcohol misuse which significantly increases hepatotoxicity risk, particularly in those who are fasting or malnourished Other medications being taken that may affect liver metabolism, including enzyme-inducing drugs (such as carbamazepine, rifampicin, or St John's wort) Adherence to recommended dosing never exceeding maximum daily limits Patients with known fatty liver disease should discuss paracetamol use with their GP or hepatologist, who can assess individual risk factors and provide personalised guidance
P., Saucier, N., Mah, A
Starting at $ 115 / Month GLP-1 receptor agonist that is FDA-approved for chronic weight management Wegovy Adults with obesity (BMI 30) or overweight (BMI 27 with a weight-related condition such as hypertension, diabetes, or high cholesterol) Start todayMore Info Potential Weight Loss* Administration methods** Injections Dose frequency*** Weekly Potential side effects Possible side effects may include nausea, vomiting, constipation, diarrhea, indigestion or stomach discomfort, reduced appetite, headache, fatigue, or injection site reactionsespecially when starting or increasing the dose
Its Precision Peptide Genetic Test is $298, or $99 for program members, and analyzes 14 pathways, 49 peptides, 150+ genetic insights, including the FTO, GLP1R, MC4R, and TCF7L2 variants shaping baseline appetite and energy balance
